公司资料
Johnson & Johnson 股价、新闻与催化剂
- 股票代码:
- JNJ
- 交易所:
- NYSE
- 行业:
- Biopharma, Small Molecule Drugs, Nucleic Acid Drugs, Novel Therapies
- 所在地:
- United States
股票表现
273.04 USD (+1.04%)
收盘价
最后更新: 2026年8月24日
537B USD
市值
股价为何变动
As of Aug 24, 2026, JNJ closed up 1.04% at $273.04. No new same-company headline was identified in the current news window.
公司概览
业务概览
Johnson & Johnson is a global healthcare leader spanning innovative medicines and medtech. Its scale, diversification, and broad therapeutic reach make it one of the most important names in the sector.
所在地与行业分类
Headquartered in the United States and listed on NYSE, J&J has a global footprint across pharmaceuticals and medical devices. It is a diversified healthcare company rather than a pure biotech or single-segment platform.
商业模式特征
The company generates value through product sales across medicines, surgery, orthopedics, and medtech franchises. Investors focus on pipeline depth, launch execution, and the ability to replace mature products with new growth drivers.
生物医药行业定位
J&J sits above the biotech cycle as a diversified healthcare bellwether. It is less volatile than development-stage biotech, but regulatory and pipeline updates still matter because they shape long-term growth expectations.
未来催化剂
- Johnson & Johnson’s near-term watchpoints are the TAR-210 uro-oncology program, RYBREVANT FASPRO rollout, and any further updates that show whether the company can keep turning new assets into commercial momentum. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。